Kaempferol nanoparticles achieve strong and selective inhibition of ovarian cancer cell viability

References

• GonzalezCARiboliEDiet and cancer prevention: where we are, where we are goingNutr Cancer20065622523117474869
   PubMed Web of Science ®Google Scholar
• HolickCNGiovannucciELRosnerBStampferMJMichaudDSProspective study of intake of fruit, vegetables, and carotenoids and the risk of adult gliomaAm J Clin Nutr20078587788617344512
   PubMed Web of Science ®Google Scholar
• BosettiCRossiMMcLaughlinJKFlavonoids and the risk of renal cell carcinomaCancer Epidemiol Biomarkers Prev2007169810117220336
   PubMed Web of Science ®Google Scholar
• HanhinevaKTörrönenRBondia-PonsIImpact of dietary polyphenols on carbohydrate metabolismInt J Mol Sci2010111365140220480025
   PubMed Web of Science ®Google Scholar
• RudkowskaIJonesPJFunctional foods for the prevention and treatment of cardiovascular diseases: cholesterol and beyondExpert Rev Cardiovasc Ther2007547749017489672
   PubMedGoogle Scholar
• BosettiCBraviFTalaminiRFlavonoids and prostate cancer risk: a study in ItalyNutr Cancer20065612312717474856
   PubMed Web of Science ®Google Scholar
• TheodoratouEKyleJCetnarskyjRDietary flavonoids and the risk of colorectal cancerCancer Epidemiol Biomarkers Prev20071668469317416758
   PubMed Web of Science ®Google Scholar
• RossiMNegriELagiouPFlavonoids and ovarian cancer risk: a case-control study in ItalyInt J Cancer200812389589818491402
   PubMed Web of Science ®Google Scholar
• DuthieGCrozierAPlant-derived phenolic antioxidantsCurr Opin Clin Nutr Metab Care2000344745111085830
   PubMed Web of Science ®Google Scholar
• HungHInhibition of estrogen receptor alpha expression and function in MCF-7 cells by kaempferolJ Cell Physiol200419819720814603522
   PubMed Web of Science ®Google Scholar
• SharmaVJosephCGhoshSAgarwalAMishraMKSenEKaempferol induces apoptosis in glioblastoma cells through oxidative stressMol Cancer Ther200762544255317876051
   PubMed Web of Science ®Google Scholar
• LeungHWLinCJHourMJYangWHWangMYLeeHZKaempferol induces apoptosis in human lung non-small carcinoma cells accompanied by an induction of antioxidant enzymesFood Chem Toxicol2007452005201317583406
   PubMed Web of Science ®Google Scholar
• CortesJRPerezGMRivasMDZamoranoJKaempferol inhibits IL-4-induced STAT6 activation by specifically targeting JAK3J Immunol20071793881388717785825
   PubMed Web of Science ®Google Scholar
• LeeKMLeeKWJungSKKaempferol inhibits UVB-induced COX-2 expression by suppressing Src kinase activityBiochem Pharmacol2010802042204920599768
   PubMed Web of Science ®Google Scholar
• García-MediavillaVCrespoIColladoPSThe anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cellsEur J Pharmacol200755722122917184768
   PubMed Web of Science ®Google Scholar
• LuoHRankinGOJulianoNJiangBHChenYCKaempferol inhibits VEGF expression and in vitro angiogenesis through a novel ERK-NFκB-cMyc-p21 pathwayFood Chem201213032132821927533
   PubMed Web of Science ®Google Scholar
• LuoHRankinGOLiZDePriestLChenYCKaempferol induces apoptosis in ovarian cancer cells through activating p53 in the intrinsic pathwayFood Chem201112851351921625365
   PubMed Web of Science ®Google Scholar
• LuoHRankinGOLiuLDaddysmanMKJiangBHChenYCKaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cellsNutr Cancer20096155456319838928
   PubMed Web of Science ®Google Scholar
• LuoHJiangBHKingSMChenYCInhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoidsNutr Cancer20086080080919005980
   PubMed Web of Science ®Google Scholar
• GatesMATworogerSSHechtJLDe VivoIRosnerBHankinsonSEA prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancerInt J Cancer20071212225223217471564
   PubMed Web of Science ®Google Scholar
• FerrariMCancer nanotechnology: opportunities and challengesNat Rev Cancer2005516117115738981
   PubMed Web of Science ®Google Scholar
• SiddiquiIAAdhamiVMAhmadNMukhtarHNanochemoprevention: sustained release of bioactive food components for cancer preventionNutr Cancer20106288389020924964
   PubMed Web of Science ®Google Scholar
• SiddiquiIAAdhamiVMChristopherJChamcheu MukhtarHImpact of nanotechnology in cancer: emphasis on nanochemopreventionInt J Nanomedicine2012759160522346353
   PubMed Web of Science ®Google Scholar
• MaXWangHJinSWuYLiangXJConstruction of paclitaxel-loaded poly (2-hydroxyethyl methacrylate)-g-poly (lactide)-1,2-dipalmitoylsn- glycero-3-phosphoethanolamine copolymer nanoparticle delivery system and evaluation of its anticancer activityInt J Nanomedicine201271313132822419875
   PubMed Web of Science ®Google Scholar
• RanganathanRMadanmohanSKesavanANanomedicine: towards development of patient-friendly drug-delivery systems for oncological applicationsInt J Nanomedicine201271043106022403487
   PubMed Web of Science ®Google Scholar
• SabnisNNairMIsraelMMcConathyWJLackoAGEnhanced solubility and functionality of valrubicin (AD-32) against cancer cells upon encapsulation into biocompatible nanoparticlesInt J Nanomedicine2012797598322393294
   PubMed Web of Science ®Google Scholar
• GrefRMinamitakeYPeracchiaMTTrubetskoyVTorchilinVLangerRBiodegradable long-circulating polymeric nanospheresScience1994263160016038128245
   PubMed Web of Science ®Google Scholar
• PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNanocarriers as an emerging platform for cancer therapyNat Nanotechnol2007275176018654426
   PubMed Web of Science ®Google Scholar
• NishiyamaNNanomedicine: nanocarriers shape up for long lifeNat Nanotechnol2007220320418654260
   PubMed Web of Science ®Google Scholar
• SiddiquiIAAdhamiVMBharaliDJIntroducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallateCancer Res2009691712171619223530
   PubMed Web of Science ®Google Scholar
• JemalASiegelRXuJWardECancer statistics, 2010CA Cancer J Clin20106027730020610543
   PubMed Web of Science ®Google Scholar
• BanksEThe epidemiology of ovarian cancerBartlettJMSOvarian Cancer: Methods and ProtocolsTotawa, NJHumana Press Inc2000
   Google Scholar
• AntoniouAPharoahPDPNarodSAverage risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studiesAm J Hum Genet2003721117113012677558
   PubMed Web of Science ®Google Scholar
• GuterresSSFessiHBarratGPuisieuxFDevissaguetJPPoly (D,L-lactide) nanocapsules containing non-steroidal anti-inflammatory drugs: gastrointestinal tolerance following intravenous and oral administrationPharm Res199512154515478584497
   PubMed Web of Science ®Google Scholar
• DuncanRPolymer conjugates as anticancer nanomedicinesNat Rev Cancer2006668870116900224
   PubMed Web of Science ®Google Scholar
• MycAKukowska-LatalloJCaoPTargeting the efficacy of a dendrimer-based nanotherapeutic in heterogeneous xenograft tumors in vivoAnticancer Drugs20102118619220010426
   PubMed Web of Science ®Google Scholar
• MaedaHTumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospectsBioconjug Chem20102179780220397686
   PubMed Web of Science ®Google Scholar
• TorchilinVTumor delivery of macromolecular drugs based on the EPR effectAdv Drug Deliv Rev20116313113520304019
   PubMed Web of Science ®Google Scholar
• SunoqrotSBaeJWPearsonRMTemporal control over cellular targeting through hybridization of folate-targeted dendrimers and PEG-PLA nanoparticlesBiomacromolecules2012131223123022439905
   PubMed Web of Science ®Google Scholar